CUMYL-PICA |
| Katalog-Nr.GC40749 |
AM2201 is a potent synthetic cannabinoid (CB) developed on an indole base with Ki values of 1.0 and 2.6 nM for the central CB1 and peripheral CB2 receptors, respectively.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1400742-32-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
AM2201 is a potent synthetic cannabinoid (CB) developed on an indole base with Ki values of 1.0 and 2.6 nM for the central CB1 and peripheral CB2 receptors, respectively.[1] CUMYL-PICA is a derivative of AM2201 with a PINACA-like chain that lacks the alkyl-terminal fluorine atom and where the naphthoyl group has been modified with the addition of a benzyl group. The physiological and toxicological properties of this compound have not been determined. This product is intended for research and forensic applications.
Reference:
[1]. Makriyannis, A., and Deng, H. Cannabimimetic indole derivatives. PCT/US00/28832, (2001).
Average Rating: 5 (Based on Reviews and 33 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *